Q2 2019 Holdings
Filed 2019-07-29 | 4 holdings | $51.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Myovant Sciences Ltd. | COM | G637AM102 | $31.4K | 3,474,645 | 60.9% |
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $20.2K | 1,558,426 | 39.1% |